{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T12:30:44Z","timestamp":1759667444550,"version":"3.37.3"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA194321"],"award-info":[{"award-number":["R01CA194321"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0231745","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T18:27:58Z","timestamp":1587061678000},"page":"e0231745","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Comparing the intra-tumoral distribution of Gemcitabine, 5-Fluorouracil, and Capecitabine in a murine model of pancreatic ductal adenocarcinoma"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7600-1155","authenticated-orcid":true,"given":"Louise M.","family":"Fanchon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagavarakishore","family":"Pillarsetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"O\u2019Donoghue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kishore","family":"Gangangari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth H.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John L.","family":"Humm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,4,16]]},"reference":[{"issue":"4","key":"pone.0231745.ref001","first-page":"251","article-title":"Molecular pathology of pancreatic cancer","volume":"7","author":"RH Hruban","year":"2001","journal-title":"Cancer journal"},{"issue":"13","key":"pone.0231745.ref002","first-page":"1558","article-title":"Inoperable pancreatic cancer: standard of care","volume":"21","author":"KB Wisinski","year":"2007","journal-title":"Oncology"},{"key":"pone.0231745.ref003","doi-asserted-by":"crossref","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","article-title":"Pancreatic cancer","volume":"2","author":"J Kleeff","year":"2016","journal-title":"Nature reviews Disease primers"},{"issue":"10","key":"pone.0231745.ref004","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S2468-1253(18)30235-8","article-title":"Chemotherapy for pancreatic cancer: the rise of multidrug regimens","volume":"3","author":"D Malka","year":"2018","journal-title":"The lancet Gastroenterology & hepatology"},{"issue":"18","key":"pone.0231745.ref005","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"DD Von Hoff","year":"2013","journal-title":"The New England journal of medicine"},{"issue":"19","key":"pone.0231745.ref006","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"T Conroy","year":"2011","journal-title":"The New England journal of medicine"},{"issue":"10073","key":"pone.0231745.ref007","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(16)32409-6","article-title":"Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial","volume":"389","author":"JP Neoptolemos","year":"2017","journal-title":"Lancet"},{"issue":"33","key":"pone.0231745.ref008","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1200\/JCO.2009.24.2446","article-title":"Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer","volume":"27","author":"D Cunningham","year":"2009","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"7","key":"pone.0231745.ref009","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.cell.2017.11.009","article-title":"Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy","volume":"171","author":"AC Palmer","year":"2017","journal-title":"Cell"},{"issue":"5933","key":"pone.0231745.ref010","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.1171362","article-title":"Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer","volume":"324","author":"KP Olive","year":"2009","journal-title":"Science"},{"issue":"1","key":"pone.0231745.ref011","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/gutjnl-2012-302529","article-title":"Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer","volume":"62","author":"MA Jacobetz","year":"2013","journal-title":"Gut"},{"issue":"6","key":"pone.0231745.ref012","doi-asserted-by":"crossref","first-page":"e67330","DOI":"10.1371\/journal.pone.0067330","article-title":"Anti-tumour efficacy of capecitabine in a genetically engineered mouse model of pancreatic cancer","volume":"8","author":"A Courtin","year":"2013","journal-title":"PloS one"},{"issue":"8","key":"pone.0231745.ref013","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0959-8049(98)00058-6","article-title":"Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue","volume":"34","author":"M Miwa","year":"1998","journal-title":"European journal of cancer"},{"issue":"3","key":"pone.0231745.ref014","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1124\/jpet.104.081265","article-title":"Hydrolysis of capecitabine to 5'-deoxy-5-fluorocytidine by human carboxylesterases and inhibition by loperamide","volume":"313","author":"SK Quinney","year":"2005","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"issue":"5","key":"pone.0231745.ref015","doi-asserted-by":"crossref","first-page":"e0196784","DOI":"10.1371\/journal.pone.0196784","article-title":"TMSOTf assisted synthesis of 2'-deoxy-2'-[18F]fluoro-beta-D-arabinofuranosylcytosine ([18F]FAC)","volume":"13","author":"KK Gangangari","year":"2018","journal-title":"PloS one"},{"issue":"6","key":"pone.0231745.ref016","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s11307-017-1078-6","article-title":"In Vitro and In Vivo Comparison of Gemcitabine and the Gemcitabine Analog 1-(2'-deoxy-2'-fluoroarabinofuranosyl) Cytosine (FAC) in Human Orthotopic and Genetically Modified Mouse Pancreatic Cancer Models","volume":"19","author":"J Russell","year":"2017","journal-title":"Molecular imaging and biology: MIB: the official publication of the Academy of Molecular Imaging"},{"key":"pone.0231745.ref017","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-1-4939-8879-2_10","article-title":"Generation and Culture of Tumor and Metastatic Organoids from Murine Models of Pancreatic Ductal Adenocarcinoma","volume":"1882","author":"LA Baker","year":"2019","journal-title":"Methods in molecular biology"},{"issue":"10","key":"pone.0231745.ref018","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.2967\/jnumed.111.091595","article-title":"Comprehensive approach to coregistration of autoradiography and microscopy images acquired from a set of sequential tissue sections","volume":"52","author":"M Axente","year":"2011","journal-title":"Journal of nuclear medicine: official publication, Society of Nuclear Medicine"},{"issue":"18","key":"pone.0231745.ref019","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1158\/0008-5472.CAN-04-0986","article-title":"Microregional effects of gemcitabine in HCT-116 xenografts","volume":"64","author":"LA Huxham","year":"2004","journal-title":"Cancer research"},{"issue":"11","key":"pone.0231745.ref020","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/FPC.0000000000000086","article-title":"PharmGKB summary: gemcitabine pathway","volume":"24","author":"ML Alvarellos","year":"2014","journal-title":"Pharmacogenetics and genomics"},{"key":"pone.0231745.ref021","doi-asserted-by":"crossref","first-page":"v7","DOI":"10.1093\/annonc\/mdj941","article-title":"Cellular pharmacology of gemcitabine","volume":"17","author":"E Mini","year":"2006","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology"},{"issue":"3","key":"pone.0231745.ref022","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2967\/jnumed.115.167650","article-title":"Measurement of Tumor Hypoxia in Patients with Advanced Pancreatic Cancer Based on 18F-Fluoroazomyin Arabinoside Uptake","volume":"57","author":"C Metran-Nascente","year":"2016","journal-title":"Journal of nuclear medicine: official publication, Society of Nuclear Medicine"},{"issue":"4","key":"pone.0231745.ref023","first-page":"919","article-title":"Pancreatic tumors show high levels of hypoxia. International journal of radiation oncology, biology","volume":"48","author":"AC Koong","year":"2000","journal-title":"physics"},{"key":"pone.0231745.ref024","first-page":"91","article-title":"The impact of hypoxia in pancreatic cancer invasion and metastasis","volume":"2","author":"A Yuen","year":"2014","journal-title":"Hypoxia"},{"issue":"9","key":"pone.0231745.ref025","doi-asserted-by":"crossref","first-page":"e46391","DOI":"10.1371\/journal.pone.0046391","article-title":"Hypoxia induces EMT in low and highly aggressive pancreatic tumor cells but only cells with cancer stem cell characteristics acquire pronounced migratory potential","volume":"7","author":"AV Salnikov","year":"2012","journal-title":"PloS one"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0231745","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T18:28:16Z","timestamp":1587061696000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0231745"}},"subtitle":[],"editor":[{"given":"Ilse","family":"Rooman","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,4,16]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0231745","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2020,4,16]]}}}